Literature DB >> 32900818

Host and Bacterial Glycolysis during Chlamydia trachomatis Infection.

Rachel J Ende1, Isabelle Derré2.   

Abstract

The obligate intracellular pathogen Chlamydia trachomatis is the leading cause of noncongenital blindness and causative agent of the most common sexually transmitted infection of bacterial origin. With a reduced genome, C. trachomatis is dependent on its host for survival, in part due to a need for the host cell to compensate for incomplete bacterial metabolic pathways. However, relatively little is known regarding how C. trachomatis is able to hijack host cell metabolism. In this study, we show that two host glycolytic enzymes, aldolase A and pyruvate kinase, as well as lactate dehydrogenase, are enriched at the C. trachomatis inclusion membrane during infection. Inclusion localization was not species specific, since a similar phenotype was observed with C. muridarum Time course experiments showed that the number of positive inclusions increased throughout the developmental cycle. In addition, these host enzymes colocalized to the same inclusion, and their localization did not appear to be dependent on sustained bacterial protein synthesis or on intact host actin, vesicular trafficking, or microtubules. Depletion of the host glycolytic enzyme aldolase A resulted in decreased inclusion size and infectious progeny production, indicating a role for host glycolysis in bacterial growth. Finally, quantitative PCR analysis showed that expression of C. trachomatis glycolytic enzymes inversely correlated with host enzyme localization at the inclusion. We discuss potential mechanisms leading to inclusion localization of host glycolytic enzymes and how it could benefit the bacteria. Altogether, our findings provide further insight into the intricate relationship between host and bacterial metabolism during Chlamydia infection.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  Chlamydia; aldolase A; glycolysis; inclusion membrane; metabolism

Mesh:

Substances:

Year:  2020        PMID: 32900818      PMCID: PMC7671904          DOI: 10.1128/IAI.00545-20

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  65 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Alterations in cancer cell metabolism: the Warburg effect and metabolic adaptation.

Authors:  Yazdan Asgari; Zahra Zabihinpour; Ali Salehzadeh-Yazdi; Falk Schreiber; Ali Masoudi-Nejad
Journal:  Genomics       Date:  2015-03-13       Impact factor: 5.736

3.  Mammalian 14-3-3beta associates with the Chlamydia trachomatis inclusion membrane via its interaction with IncG.

Authors:  M A Scidmore; T Hackstadt
Journal:  Mol Microbiol       Date:  2001-03       Impact factor: 3.501

4.  Combined Human Genome-wide RNAi and Metabolite Analyses Identify IMPDH as a Host-Directed Target against Chlamydia Infection.

Authors:  Marion Rother; Erik Gonzalez; Ana Rita Teixeira da Costa; Lea Wask; Isabella Gravenstein; Matteo Pardo; Matthias Pietzke; Rajendra Kumar Gurumurthy; Jörg Angermann; Robert Laudeley; Silke Glage; Michael Meyer; Cindrilla Chumduri; Stefan Kempa; Klaus Dinkel; Anke Unger; Bert Klebl; Andreas Klos; Thomas F Meyer
Journal:  Cell Host Microbe       Date:  2018-04-26       Impact factor: 21.023

5.  Use of aminoglycoside 3' adenyltransferase as a selection marker for Chlamydia trachomatis intron-mutagenesis and in vivo intron stability.

Authors:  Nicole M Lowden; Laxmi Yeruva; Cayla M Johnson; Anne K Bowlin; Derek J Fisher
Journal:  BMC Res Notes       Date:  2015-10-15

6.  Structural basis for the hijacking of endosomal sorting nexin proteins by Chlamydia trachomatis.

Authors:  Blessy Paul; Hyun Sung Kim; Markus C Kerr; Wilhelmina M Huston; Rohan D Teasdale; Brett M Collins
Journal:  Elife       Date:  2017-02-22       Impact factor: 8.140

7.  Genetic Inactivation of Chlamydia trachomatis Inclusion Membrane Protein CT228 Alters MYPT1 Recruitment, Extrusion Production, and Longevity of Infection.

Authors:  Jennifer H Shaw; Charlotte E Key; Timothy A Snider; Prakash Sah; Edward I Shaw; Derek J Fisher; Erika I Lutter
Journal:  Front Cell Infect Microbiol       Date:  2018-11-30       Impact factor: 5.293

8.  Comprehensive Flux Modeling of Chlamydia trachomatis Proteome and qRT-PCR Data Indicate Biphasic Metabolic Differences Between Elementary Bodies and Reticulate Bodies During Infection.

Authors:  Manli Yang; Karthika Rajeeve; Thomas Rudel; Thomas Dandekar
Journal:  Front Microbiol       Date:  2019-10-15       Impact factor: 5.640

Review 9.  The structural and functional coordination of glycolytic enzymes in muscle: evidence of a metabolon?

Authors:  Lynda Menard; David Maughan; Jim Vigoreaux
Journal:  Biology (Basel)       Date:  2014-09-22

10.  Chlamydia trachomatis inclusion membrane protein MrcA interacts with the inositol 1,4,5-trisphosphate receptor type 3 (ITPR3) to regulate extrusion formation.

Authors:  Phu Hai Nguyen; Erika I Lutter; Ted Hackstadt
Journal:  PLoS Pathog       Date:  2018-03-15       Impact factor: 6.823

View more
  2 in total

1.  Chlamydia trachomatis RsbU Phosphatase Activity Is Inhibited by the Enolase Product, Phosphoenolpyruvate.

Authors:  Christopher Rosario; Ming Tan
Journal:  J Bacteriol       Date:  2022-09-19       Impact factor: 3.476

2.  The Chlamydia trachomatis Inclusion Membrane Protein CTL0390 Mediates Host Cell Exit via Lysis through STING Activation.

Authors:  R Clayton Bishop; Isabelle Derré
Journal:  Infect Immun       Date:  2022-05-19       Impact factor: 3.609

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.